186 related articles for article (PubMed ID: 10721715)
1. Activation of human gamma-globin gene expression via triplex-forming oligonucleotide (TFO)-directed mutations in the gamma-globin gene 5' flanking region.
Xu XS; Glazer PM; Wang G
Gene; 2000 Jan; 242(1-2):219-28. PubMed ID: 10721715
[TBL] [Abstract][Full Text] [Related]
2. Induction of endogenous gamma-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence.
Xu XS; Hong X; Wang G
J Hematol Oncol; 2009 Mar; 2():15. PubMed ID: 19327156
[TBL] [Abstract][Full Text] [Related]
3. T to C substitution at -175 or -173 of the gamma-globin promoter affects GATA-1 and Oct-1 binding in vitro differently but can independently reproduce the hereditary persistence of fetal hemoglobin phenotype in transgenic mice.
Liu LR; Du ZW; Zhao HL; Liu XL; Huang XD; Shen J; Ju LM; Fang FD; Zhang JW
J Biol Chem; 2005 Mar; 280(9):7452-9. PubMed ID: 15613485
[TBL] [Abstract][Full Text] [Related]
4. Human gamma-globin gene promoter element regulates human beta-globin gene developmental specificity.
Ryan TM; Sun CW; Ren J; Townes TM
Nucleic Acids Res; 2000 Jul; 28(14):2736-40. PubMed ID: 10908330
[TBL] [Abstract][Full Text] [Related]
5. Gamma-globin gene promoter elements required for interaction with globin enhancers.
Langdon SD; Kaufman RE
Blood; 1998 Jan; 91(1):309-18. PubMed ID: 9414299
[TBL] [Abstract][Full Text] [Related]
6. Peptide nucleic acid (PNA) binding-mediated induction of human gamma-globin gene expression.
Wang G; Xu X; Pace B; Dean DA; Glazer PM; Chan P; Goodman SR; Shokolenko I
Nucleic Acids Res; 1999 Jul; 27(13):2806-13. PubMed ID: 10373600
[TBL] [Abstract][Full Text] [Related]
7. Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin.
Gumucio DL; Rood KL; Gray TA; Riordan MF; Sartor CI; Collins FS
Mol Cell Biol; 1988 Dec; 8(12):5310-22. PubMed ID: 2468996
[TBL] [Abstract][Full Text] [Related]
8. Activation of delta-globin gene expression by erythroid Krupple-like factor: a potential approach for gene therapy of sickle cell disease.
Donze D; Jeancake PH; Townes TM
Blood; 1996 Nov; 88(10):4051-7. PubMed ID: 8916973
[TBL] [Abstract][Full Text] [Related]
9. LCR-regulated transgene expression levels depend on the Oct-1 site in the AT-rich region of beta -globin intron-2.
Bharadwaj RR; Trainor CD; Pasceri P; Ellis J
Blood; 2003 Feb; 101(4):1603-10. PubMed ID: 12393478
[TBL] [Abstract][Full Text] [Related]
10. A naturally occurring gamma globin gene mutation enhances SP1 binding activity.
Sykes K; Kaufman R
Mol Cell Biol; 1990 Jan; 10(1):95-102. PubMed ID: 1688466
[TBL] [Abstract][Full Text] [Related]
11. Sites I and II upstream of the A gamma globin gene bind nuclear factors and affect gene expression.
Lloyd JA; Lee RF; Menon AG; Lingrel JB
Prog Clin Biol Res; 1989; 316A():139-48. PubMed ID: 2480607
[TBL] [Abstract][Full Text] [Related]
12. Protein-DNA interactions upstream from the human A gamma globin gene.
O'Neill D; Kaysen J; Donovan-Peluso M; Castle M; Bank A
Nucleic Acids Res; 1990 Apr; 18(8):1977-82. PubMed ID: 2336386
[TBL] [Abstract][Full Text] [Related]
13. Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment.
Ebb D; Tang DC; Drew L; Chin K; Berg PE; Rodgers GP
Blood Cells Mol Dis; 1998 Sep; 24(3):356-69. PubMed ID: 10087993
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the human beta-globin downstream promoter region.
Leach KM; Vieira KF; Kang SH; Aslanian A; Teichmann M; Roeder RG; Bungert J
Nucleic Acids Res; 2003 Feb; 31(4):1292-301. PubMed ID: 12582249
[TBL] [Abstract][Full Text] [Related]
15. Factor binding to the human gamma-globin gene distal CCAAT site: candidates for repression of the normal gene or activation of HPFH mutants.
Partington GA; Patient RK
Br J Haematol; 1998 Sep; 102(4):940-51. PubMed ID: 9734644
[TBL] [Abstract][Full Text] [Related]
16. Protein-DNA interactions in the epsilon-globin gene silencer.
Peters B; Merezhinskaya N; Diffley JF; Noguchi CT
J Biol Chem; 1993 Feb; 268(5):3430-7. PubMed ID: 8429019
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.
Carbone GM; McGuffie EM; Collier A; Catapano CV
Nucleic Acids Res; 2003 Feb; 31(3):833-43. PubMed ID: 12560478
[TBL] [Abstract][Full Text] [Related]
18. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M
Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478
[TBL] [Abstract][Full Text] [Related]
19. Triplex-forming peptide nucleic acids induce heritable elevations in gamma-globin expression in hematopoietic progenitor cells.
Chin JY; Reza F; Glazer PM
Mol Ther; 2013 Mar; 21(3):580-7. PubMed ID: 23337982
[TBL] [Abstract][Full Text] [Related]
20. The role of trans-acting factors and DNA-bending in the silencing of human beta-globin gene expression.
Drew LR; Tang DC; Berg PE; Rodgers GP
Nucleic Acids Res; 2000 Jul; 28(14):2823-30. PubMed ID: 10908341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
